Inactive Instrument

CV Sciences Inc Stock OTC Bulletin Board

Equities

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for CV Sciences Inc
Sales 2022 16.2M Sales 2023 16M Capitalization 5.47M
Net income 2022 -9M Net income 2023 3M EV / Sales 2022 0.36 x
Net Debt 2022 917K Net cash position 2023 875K EV / Sales 2023 0.29 x
P/E ratio 2022
-0.44 x
P/E ratio 2023
1.77 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 99.98%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 66 14-06-15
Director of Finance/CFO 49 18-12-25
Members of the board TitleAgeSince
Chief Executive Officer 66 14-06-15
Director/Board Member 54 22-07-20
Director/Board Member 56 22-10-20
More insiders
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
More about the company